A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus
Public ClinicalTrials.gov record NCT05593432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study will be to evaluate efficacy and safety of Ruxolitinib cream in participants With Cutaneous Lichen Planus. This is randomized, double-blind, vehicle-controlled (DBVC) study with a DBVC period of 16 weeks followed by an open label period (OLE) period of 16 weeks.
Study identification
- NCT ID
- NCT05593432
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 23, 2022 (Actual)
- Primary completion
- Oct 2, 2023 (Actual)
- Completion
- Feb 26, 2024 (Actual)
- Last update posted
- Oct 24, 2024
2022 – 2024
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology | Birmingham | Alabama | 35244 | — |
| Medical Dermatology Specialists Phoenix | Phoenix | Arizona | 85006 | — |
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Wallace of Beverly Hills | Los Angeles | California | 90056 | — |
| Northshore Medical Group Dermatology Skokie | Skokie | Illinois | 60077 | — |
| Dawes Fretzin Clinical Research Group Llc | Indianapolis | Indiana | 46250 | — |
| Delricht Clinical Research-Clinedge-Ppds Baton Rouge | Baton Rouge | Louisiana | 70809 | — |
| Delricht Research - Touro Medical Center | New Orleans | Louisiana | 70115 | — |
| Dermassociates | Rockville | Maryland | 20850 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| Jdr Dermatology Research | Las Vegas | Nevada | 89148 | — |
| OPTISKIN | New York | New York | 10128 | — |
| Bexley Dermatology | Bexley | Ohio | 43209 | — |
| Clinohio Research Services | Columbus | Ohio | 43213 | — |
| Apex Clinical Research Center | Mayfield Heights | Ohio | 44124 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| University of Pennsylvania-Perelman School of Medicine | Philadelphia | Pennsylvania | 19104-5160 | — |
| International Clinical Research Ic Research Murfreesboro | Murfreesboro | Tennessee | 37130-2450 | — |
| Arlington Center For Dermatology | Arlington | Texas | 76011-3800 | — |
| Austin Institute For Clinical Research Aicr Pflugerville | Pflugerville | Texas | 78660 | — |
| University of Utah Health Care Midvalley Health Center Dermatology | Murray | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05593432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05593432 live on ClinicalTrials.gov.